XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total Stockholder's Equity [Member]
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Deferred Compensation [Member]
Noncontrolling Interests [Member]
Series B Preferred Stock
Total
Beginning Balance at Oct. 31, 2020 $ 194,548 $ 29 $ 1,359,454 $ (1,164,196) $ (739) $ (432) $ 432     $ 194,548
Beginning Balance at (in shares) at Oct. 31, 2020   294,706,758                
Sale of common stock, net of fees 156,366 $ 3 156,363             156,366
Sale of common stock, net of fees (in shares)   25,000,000                
Orion warrant exercises and other warrant exercises 21,824   21,824             21,824
Orion warrant exercises and other warrant exercises (in shares)   2,700,000                
Common stock issued, non-employee compensation 45   45             45
Common stock issued, non-employee compensation, (in shares)   2,734                
Share based compensation 1,417   1,417             1,417
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards 8   8             8
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (shares)   4,521                
Preferred dividends - Series B (800)   (800)           $ (800) (800)
Effect of foreign currency translation 58       58         58
Adjustment for deferred compensation           (30) 30      
Adjustment for deferred compensation (in shares)   (1,669)                
Release of a share reserve   (48)                
Net loss (45,960)     (45,960)           (45,960)
Ending Balance at Jan. 31, 2021 327,506 $ 32 1,538,311 (1,210,156) (681) (462) 462     327,506
Ending Balance at (in shares) at Jan. 31, 2021   322,412,296                
Beginning Balance at Oct. 31, 2021 642,438 $ 37 1,908,471 (1,265,251) (819) (586) 586     $ 642,438
Beginning Balance at (in shares) at Oct. 31, 2021   366,618,693               366,618,693
Common stock issued, non-employee compensation 100   100             $ 100
Common stock issued, non-employee compensation, (in shares)   20,673                
Share based compensation 1,470   1,470             1,470
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (260)   (260)             (260)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (shares)   60,052                
Preferred dividends - Series B (800)   (800)           $ (800) (800)
Effect of foreign currency translation (91)       (91)         (91)
Adjustment for deferred compensation           (64) 64      
Adjustment for deferred compensation (in shares)   (13,232)                
Net loss attributable to redeemable noncontrolling interest 5,496     5,496       $ (5,496)   5,496
Net loss (46,120)     (46,120)           (46,120)
Ending Balance at Jan. 31, 2022 $ 602,233 $ 37 $ 1,908,981 $ (1,305,875) $ (910) $ (650) $ 650 $ (5,496)   $ 596,737
Ending Balance at (in shares) at Jan. 31, 2022   366,686,186               366,686,186